Since cognitive deterioration is associated with higher Aβ-PET, hippocampal volumetric reduction on MRI, glucose hypometabolism on FDG-PET, and increased tau levels [32,33], a study combined the multimodal data to develop a biomarker-based machine learning algorithm to predict progression of cognitive deterioration in AD [34]. Here, MAPT is linked to Alzheimer disease.